| Name: | Candesartan Cilexetil EP Impurity E |
| Catalogue No. | VL290003 |
| CAS No. | 914613-35-7 |
| Molecular Formula | C35H38N6O6 |
| Molecular Weight | 638.71 |
| Status | In-stock |
| IUPAC Name | 2-Ethoxy-1-[[2'-[1-ethyl-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic |
| Synonyms | Candesartan Cilexetil N1-Ethyl Analog / Candesartan Impurity 6 |
| Appearance | Off White Solid |
| Description | Candesartan Cilexetil EP Impurity E (CAS No: 914613-35-7) or 2 –Ethoxy- 1-[[2’-( -ethyltetrazol-5-yl)biphenyl-4-yl]methyl]-1 H-benzimidazol-7-carbonsaure 1 – ([(cyclohexyloxy)carbonyl]oxy)ethyleste,it is an impurity of Candesartan Cilexetil,Candesartan Cilexetil is an ester prodrug of candesartan, which belongs to the angiotesin-II receptor antagonists,which is used in the treatment of hypertension. |
| References | Sci-Hub | The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial | 10.1016/s0140-6736(11)60104-9. (2022). Retrieved January 1, 2022, from Sci-hub.ee website: https://sci-hub.ee/10.1016/s0140-6736(11)60104-9 |
